Industry roundtable discussions inform AHSN Network support offer

The AHSN Network, of which the West of England AHSN is a member, is planning a series of “Bridging the gap” events this autumn aimed at providing support, information and advice for innovators across industry. The plans have been developed following a roundtable discussion hosted by the AHSN Network to listen to the experiences and challenges faced by industry during the COVID-19 pandemic.

The roundtable, titled Lessons learned and lived experiences of industry during the pandemic – how these can help us reset health and care together, was primarily an opportunity to hear from industry. The group discussed how the views and experiences of industry could be taken forward and inform the NHS Reset process as we move into “phase 3” of the response to the pandemic. You can watch a short film summarising the event here.

In essence, the key themes of discussion around actions that need to involve industry insights to support reset included:

  • Effectively embedding new care/service models that have developed during the pandemic
  • Getting rapid evaluation and reimbursement models working more effectively, building on the lessons learned in recent months
  • Managing the consequences of the dramatic decrease in non-COVID care and considering digital interventions that can help manage patient care and outcomes.

Organisations joining the AHSN Network in this virtual roundtable included:

  • the Association of the British Pharmaceutical Industry (ABPI),
  • the British In Vitro Diagnostic Association (BIVDA),
  • the Digital Health and Care Alliance (DHACA),
  • the Association of British Health Industries (ABHI),
  • Health Foundation,
  • Accelerated Access Collaborative (AAC),
  • NHSX,
  • the Office for Life Sciences (OLS),
  • Spirit Health Group, and
  • the NHS Confederation.

Niall Dickson, Chief Executive of the NHS Confederation, said:

“The NHS has been through the most traumatic period in its history – we have seen some of most awful consequences of this terrible pandemic and some of the most fantastic responses from both health and care staff.

“We have seen innovation and its implementation at an unimaginable speed and scale that’s never been seen before, and we now urgently need to review what has happened and make sure we capture the positive transformations have been made possible by working with industry.

“We are keen for these relationships to continue and for us all to work hard to maintain this momentum.”

Read more about the event here.

This event forms part of the AHSN Network work on supporting the health and care reset, ensuring that we work across both NHS and industry to sustain and maximise on potential advances and transformative ways of working.

New King’s Fund report on transformative technology for long-term health conditions

A new King’s Fund report, part funded by the West of England AHSN, titled Technology and innovation for long-term health conditions uses four unique case studies to outline and discuss key themes of effective implementation of digital innovation.

AHSNs commissioned the King’s Fund to explore four different digital innovations in health services from the UK and the Nordic countries in order to demonstrate transformative potential and compare and contrast themes across geographies. The paper acts as a continuation of the AHSN’s commitment to learn from and take a collaborative approach to innovation transnationally with countries that form the Northern Future Forum (Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway, Sweden and the United Kingdom). This follows an initial Innovation Leadership Exchange event in September 2019, attended by senior leaders within health and care across the Northern Future Forum countries.

The paper also recognises the rapid uptake of digital innovation driven by the COVID-19 pandemic and outlines some of the questions services need to answer to sustain and implement digital technologies effectively going forward.

One of the case studies featured in the report is UK-based social enterprise, Patients Know Best who provide an online patient portal offering patients and health care staff a safe and secure way of exchanging information and giving patients access to their medical records.

One key feature of Patients Know Best’s approach is to put patients in charge, ensuring that they can access all the information about themselves in real time. Patients decide who else can access their information and allow new health care staff to join their team when needed, for example, when a GP or accident and emergency staff need to see their care plans.

Patients Know Best have been supported by a number of regional AHSNs since 2016 and has been adopted in more than 70 NHS trusts in England and can be accessed by more than five million NHS patients.

Other case studies include:

  • TeleCare North programme, which provides remote treatment for people with chronic obstructive pulmonary disease (COPD)
  • Helsinki University Hospital’ remote diabetes monitoring programme for children
  • Huoleti app that connects patients with a support network.

The case studies illustrate the potential of digital technology to transform care, particularly through empowering patients, supporting stronger therapeutic relationships and effective teamworking across professional boundaries, and creating networks and communities to support patients.

Some key areas of discussion highlighted in the report include:

  • Responsive services for unpredictable diseases
  • Technology-enabled teamworking
  • Relationships enabled by technology
  • Collaborative design
  • Iterative cycles of improvement

The paper also calls on health and care providers to assess the impact on staff and patients of the rapid transition to online services driven by the COVID-19 pandemic, to ensure changes are fully assessed and to question whether there is scope to be more ambitious in redesigning services.

Read the report here. 

Quality Improvement in the age of COVID – launching PERIPrem

Noshin Menzies, Senior Project Manager, shares her experiences of launching a Quality Improvement programme during COVID.

If you’d told me 4 months ago we would be where we are today with PERIPRem, I’d have wondered what planet you were from. This exciting, ambitious care bundle, the vision of two extraordinary neonatologists, was going to launch in April and change the way that perinatal care is delivered across the entire South West region. It was a seed reliant on collaboration. However, 2020 had other plans…

The fundamentals of PERIPRem – nurturing a regional clinical community dedicated to improving outcomes for our most vulnerable babies and working side by side with women and their families – were, in an instant, stopped in their tracks.

Pre-COVID, I had been lucky enough to attend the Royal College of Obstetrics and Gynaecology’s “Let’s Talk about Race” event for International Women’s Day. The stories I heard further cemented the commitment we had to reducing inequalities.  We could not deliver a perinatal quality improvement project without ensuring that we were actively listening – and considering how to chip away at the barriers that result in Black and Minority Ethnic women being 5 times more likely to die in childbirth and their children to experience poorer outcomes. This was even before we knew the increased risk of COVID to people of colour and the raised chance of preterm labour for those women unfortunate enough to contract the virus whilst pregnant.

Just as we finalised plans for launch, and to get out into the communities and find every opportunity to involve those who lives are imprinted by the experience of preterm birth, COVID hit. Our PERIPRem teams were now on the battle lines, and we were nestled behind our laptop screens, shell shocked. Our ability to be agile and adapt to novel ways of working mattered now more than ever.

I’ll admit, I was sceptical how we could launch what was still a seedling of a programme to twelve units across the whole of the South West, when we were unable to leave our kitchens, let alone realise our plans to provide fertile ground for the creation of a regional PERIPRem clinical community. Without a physical launch, how could we provide space for those small but mighty moments, that when cultivated, have more of an impact than any toolkit or presentation?

I often struggle when I have to describe QI; in my experience it is much bigger than a framework or a process by which you can input your problem and wait for gold-standard results. For me, QI has its foundations in the people, the team and the culture. It is the introductions to new faces, teams huddled together around meeting tables, clinicians whispering to colleagues they had not seen for years and the camaraderie brewed alongside the substandard coffee.  We grow highly functioning teams, and the most exciting part of any QI project, on these blocks. It was boom or bust but I needn’t have worried.

We have formed strong bonds as a PERIPRem team; we have even managed a team social. My treasured counterpart in the South West AHSN and I have never met, we joke that we do not know what each other look like from the shoulders down. We have bonded over the many cameos from the PERIPRem teams’ children – or Assistant QI Coaches as they are now known.

Most importantly, the PERIPRem perinatal teams have flourished. Whilst in the pressure cooker of the pandemic, we gave space and time to focus on delivering patient care – when they got a handle on what it meant for them as clinicians, they came back raring to go.  We have digitised all of our resources and are now holding webinars on each of the bundle elements – they are so well attended we cannot fit on a screen!

People have pushed through discomfort to record themselves sharing the clinical fundamentals and to provide the presence (all be it through a screen) we all miss. We are exploring new ways to engage with the women we were so keen to meet and listen to, and we are forever indebted to our patient representatives who are now pillars of our PERIPRem team.

The takeaway message from that tired trope of “these unprecedented times” is that we are stronger than we think. At the end of each exhausting day, when we have had our fill of fighting for bandwidth with Xboxing teenagers, with tired mouths from calmly saying, “you’re on mute”, we have been and will continue to be successful. More significantly, we have supported frazzled teammates, butted horns and laughed until we cried.

There is a sense of freedom this way of working has granted us. Whilst before, there was a tendency to stick to the tried and tested method of engaging and working with our clinical communities, COVID allowed us to think again. We used technology to enable hospital teams scattered across the entire southwest to meaningfully engage in PERIPRem without ever having to leave their wards. I was worried connecting through screens and keyboards would reinforce the distance between us all, but I am surprised to realise that it has in fact accelerated relationships and in turn progress.

Having to rely on the written word in email has meant that tone and intonation have been more carefully considered and the periods of chat offered through video calls means each sentence really counts. Of more significance, is a flattening of the hierarchy within our team. Each person no matter what their seniority is vital in keeping the PERIPRem wheel turning – be it because they know how to record a MS Teams meeting, or because they have the complex clinical knowledge of a perinatal intervention.  It is not that we did not appreciate this before, but the situation forced us to see beyond the limitations of a job description.

I have reflected on whether, upon return to ‘normality’, if we as a team will revert to the pre-COVID way of working. Whilst I would like to think there would be a time when we are able to sit in offices and meet with units, I do not think that is the whole question. I can honestly say I hope we do not – I do not want to forget our swift response to the restrictions placed on us, or our unwavering faith in our ability to make improvements.

I believe that we have fundamentally changed the way we will approach projects such as this in the future. We are braver in our ways of facilitating community, we have lived experience of delivering change programmes utilising technology rather than travel and we know that when needed, we can free ourselves of the legacy of traditional and more restrictive ways of working.

West of England innovator tapped to transform England’s NHS through national acceleration

On 5 March, the NHS Innovation Accelerator (NIA) announced 11 high impact innovations joining the national accelerator in 2020, including one developed here in the West of England: The WaterDrop.

Developed by Mark Moran MBE, The WaterDrop is a low-cost, high-impact innovation enabling patients to easily access fluids at any time without needing to call for help. This innovation helps prevent dehydration and avoidable intravenous drips and could provide a breakthrough in a variety of health and social care settings. Mark received support for The WaterDrop back in 2016 through the Health Innovation Programme (HIP), our immersive bootcamp for healthcare entrepreneurs.

At a launch event chaired by Professor Stephen Powis, National Medical Director for NHS England and NHS Improvement, the 2020 cohort of Fellows presented their innovations to key stakeholders, including including Tony Young, National Clinical Lead for Innovation of NHS England and NHS Improvement, and Nigel Edwards, Chief Executive of the Nuffield Trust.

All of the innovations joining the award-winning NIA offer solutions supporting priority areas for England’s NHS as laid out in the NHS Long Term Plan. Their recruitment follows an international call and rigorous selection process, including review by over 100 clinical, patient and commercial assessors (including three from the West of England AHSN), alongside informal review by the National Institute for Health and Care Excellence (NICE). The newly appointed group also includes a medically certified smartwatch app capable of detecting atrial fibrillation (AF), a device reducing the angst of parents by enabling faster ADHD diagnosis, and an artificial intelligence (AI) platform bringing patients’ voices to life to improve care.

This marks the fifth year of the NIA, which is an NHS England initiative delivered in partnership with England’s 15 Academic Health Science Networks (AHSNs), hosted at UCLPartners. Since 2015, it has supported the uptake and spread of 62 evidence-based innovations across more than 2,210 NHS sites. Independent evaluations report that NIA innovations save the health and social care system at least £38 million a year.

Alex Leach, our Deputy Director of Innovation and Growth, who contributed to the 2020 NIA selection process and attended the launch event in London, said:

“It’s fantastic to see an innovator and one of our HIP Alumni from the West of England selected for the NHS Innovation Accelerator. We know the innovations supported through the NIA make a real difference to the NHS, our economy, and most importantly patients and service users.

“At the West of England AHSN, we’ll continue to offer our support to The WaterDrop and all the 2020 Fellows to support adoption and spread of innovation across our footprint. The next round of NIA applications open later this year; I would encourage anyone thinking about applying or starting out on their innovator journey to get in touch.”

Piers Ricketts, Chair of the AHSN Network, said:

“The NHS Innovation Accelerator is one of the flagship programmes of the AHSN Network. NIA Fellows have made a huge contribution to our health and care system since we started the programme five years ago, and we are proud to have supported these remarkable individuals on their development journey. It is gratifying to see their high-impact innovations gaining traction and visibility through our accelerator programme, and we are delighted that several NIA innovations have now had national impact in the NHS.

We look forward to working with the new NIA Fellows to help them scale and deploy their innovations across the country for the benefit of patients and the NHS.”

About the NHS Innovation Accelorator (NIA):

The NIA is an NHS England Initiative delivered in partnership with England’s 15 Academic Health Science Networks (AHSNs), hosted by UCLPartners. Highlighted in the NHS Long Term Plan, it accelerates uptake of high impact innovations for patient, population and NHS staff benefit, and providing real time practical insights on spread to inform national strategy.

The NIA supports individuals (‘Fellows’) with a set of values and passion for scaling evidence-based innovation to benefit a wider population, with a commitment to share their learnings.

Since launching in July 2015, the NIA has delivered the following:

  • 2,214 additional NHS sites using NIA innovations
  • £134.8m external funding raised
  • 486 jobs created
  • 113 awards won
  • 45 innovations selling internationally
  • NIA innovations save the health and social care system £38m per annum, according to conservative figures from independent evaluations by York Health Economic Consortium

Recent highlights of our work together

The West of England AHSN continues to be recognised for successfully bringing together healthcare, industry and academic partners across the region – but what are we are actually achieving together? Here are a few highlights from the last quarter, October to December 2015…

Patient safety

  • 10,000 people have benefitted from the emergency department safety checklist so far this last year, which has been piloted by University Hospitals Bristol NHS Foundation Trust. We are now supporting four other EDs to implement the checklist: Weston Area Health NHS Trust, North Bristol NHS Trust, Gloucestershire Hospitals NHS Foundation Trust, and Great Western Hospitals NHS Foundation Trust.
  • The two Bristol Trusts have successfully converted from the Bristol Early Warning Score to the National Early Warning Score (NEWS).
  • A great example of collaborative working: 80 delegates from across the South of England attended our Mental Health Collaborative learning event in December.
  • The Emergency Laparotomy Collaborative is live including all six acute trusts. This work will benefit 1,000 patients a year in the West of England.
  • To date, 435 staff from community organisations have already received Human Factors training. We are now providing funding to Bath & North East Somerset CCG, Bristol Community Health, Gloucestershire Care Services and North Somerset Community Partnership to enable a further 2,500 staff in community settings to receive training.

Informatics

  • Connecting Care has been used to review patient records on 110,000 occasions. Gloucestershire CCG has a final business case which will deliver interoperability in 2016/17. Wiltshire and BaNES are enhancing local systems to connect data for patient benefit across care settings.
  • Patients in the West of England are set to benefit from a new NHS Genomic Medicine Centre based in Bristol, which gained approval in December.

Quality improvement

  • 80 GP practices in Gloucestershire are working with us on our Atrial Fibrillation programme. The first 11 practices found 533 high risk patients who may need clinical review.
  • We have trained 46 GPs, 15 nurse practitioners and health care assistants, and 12 pharmacists as part of Don’t Wait to Anticoagulate, with a further pharmacist training session planned.

OpenPrescribing

  • The OpenPrescribing platform been used on 25,000 occasions, with 94,000 page views, and shares on Twitter have reached a potential audience of 46 million people. The concept has now spread to Wales and Scotland.

Join Dementia Research

  • At Christmas the West of England had achieved number one slot for the highest number of local registrations to the Join Dementia Research service in the country.

Diabetes Digital Coach

  • The Diabetes Digital Coach programme, developed by a consortium led by the West of England AHSN, has been selected as an ‘internet of things’ Test Bed to help people with diabetes in the region self-manage their condition.

Supporting innovation

  • We have supported Folium Optics who have been awarded £1 million funding from SBRI Healthcare competition to further developed their ‘smart tag’ which reminds people to take their medication.

Everything we do and achieve is in collaboration with an extensive range of individuals and organisations across the West of England and beyond. Thank you to all our members, partners, public contributors and staff!

Reinforcing the power of AHSNs

Chief Executive of the NHS Confederation, Rob Webster visited the West of England AHSN on Tuesday 2 February and was clearly impressed by the work he saw being developed by our network.

Writing in his regular news briefing later that week, he said:

“We need to do what is in our gift within our organisations, as evidenced by the brilliant work on ‘crowding’ coming out of the Bristol Royal Infirmary. The excellent Dr Emma Redfern shared work on National Early Warning Scores (NEWS) and the development of an ED checklist that is saving lives and improving services. The work is spreading across the South West, under the Patient Safety Collaborative supported by the West of England AHSN.

“The AHSNs are currently collating their top three innovations for a compendium – after half a day at the brilliant WEAHSN, they will struggle to get it down to only three each.

“There are some days when you feel you are stealing a living and this was one of them. From the PreCePT work on preventing cerebral palsy in preterm babies to risk factors in atrial fibrillation in general practice, the work is clinically-led, evidence-based and having impact. Lives are being saved, clinicians enthused and the public informed. Check out things like dontwaittoanticoagulate.com and www.openprescribing.net for examples of what they do.

“Thanks to Deborah Evans and her team at West of England AHSN for reinforcing the power of AHSNs. It was timely as Sir Hugh Taylor and I met this week to discuss how AHSNs play into the final recommendations of the Accelerated Access Review.”

 

Gloucestershire Hospitals’ Biophotonics Research Unit scoop innovation award

The Staff Awards 2015 for Gloucestershire Hospitals NHS Foundation Trust took place at Hatherley Manor last month, celebrating the hard work, loyalty and dedication of teams and individuals across the organisation.

The West of England AHSN was delighted to sponsor the Innovation Award, which was won by Professor Hugh Barr, Dr Catherine Kendall, Dr Gavin Lloyd of the Biophotonics Research Unit (BRU) team.

They were selected for their commitment to high quality research and innovation to improve the diagnosis and treatment of patients – and also for that very special ability which each of them has to inspire others – their colleagues, their peers and the scientists and clinicians of the future.

The application of this science holds enormous potential for improving the diagnosis and treatment of disease, including cancer

Progress in medicine and clinical care would never come about without the skills and enthusiasm of our researchers and innovators. A number of the Trust’s clinicians and scientists have been at the leading edge of novel advances in medicine over the years – and amongst this group are the members of the BRU team.

Biophotonics is the science of the interaction of light with tissue, which holds enormous potential for improving the diagnosis and treatment of disease, including cancer.

The BRU is a multidisciplinary team of clinicians and scientists working closely together, focused on translating science into the clinical environment and driving innovation forward.

The Unit was established 20 years ago by Professor Barr, a Consultant Upper GI Surgeon, who was inspired to develop new ways of diagnosing and treating disease – in particular oesophageal cancer. He remains Clinical Lead for the Unit, alongside Dr Catherine Kendall, Consultant Clinical Scientist who is the Scientific Lead. Dr Gavin Lloyd is a research fellow, with expertise in the field of chemometrics (data analysis).

The Unit creates opportunities for a wider team of clinicians and scientists to carry out high quality research and to gain higher degrees. Their contribution is invaluable in developing the research, which is funded by national and international grants.

The research focuses particularly on the clinical applications of Raman and Infrared spectroscopy. These technologies are being developed as a diagnostic platform for a range of clinical applications.

Collaborations both national, international and with industry are vital for the development of this research, in particular with Prof Nick Stone at the University of Exeter and Dr John Day at University of Bristol. Commercialisation aspects of the work are explored in conjunction with NHS Innovations SW.

A particular strength is that the Unit is not isolated, but is embedded as a recognised department within the Trust, much valued by colleagues for the wider contribution which it makes to the work of the hospitals.

As well as being outstanding in their clinical and scientific fields, each of these three colleagues also have a very special ability to communicate their science and to inspire others – their colleagues, their peers, and through their work with young people, the scientists and clinicians of the future.

The United Nations designated 2015 as the International Year of Light and Light-based Technologies, which makes it all the more fitting to these three leading members of the Biophotonics Research Unit won this award this year.